{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:11:31Z","timestamp":1767611491068,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Endo Pharmaceuticals Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.urology.2020.08.045","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T09:12:34Z","timestamp":1599210754000},"page":"145-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification"],"prefix":"10.1016","volume":"146","author":[{"given":"Irwin","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"McLane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinfang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry R.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.","family":"Gelbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2020.08.045_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/tau.2016.11.01","article-title":"Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction","volume":"6","author":"Campbell","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.sxmr.2019.02.004","article-title":"Pathophysiology and future therapeutic perspectives for resolving fibrosis in Peyronie's disease","volume":"7","author":"Milenkovic","year":"2019","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2020.08.045_bib0003","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/sj.ijir.3901247","article-title":"Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction","volume":"16","author":"Kadioglu","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.urology.2020.08.045_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150157","article-title":"The prevalence of Peyronie's disease in the United States: a population-based study","volume":"11","author":"Stuntz","year":"2016","journal-title":"PLoS One"},{"issue":"suppl 5","key":"10.1016\/j.urology.2020.08.045_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bju.14605","article-title":"Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia","volume":"122","author":"Chung","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2020.08.045_bib0006","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2020.08.045_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"DiBenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0008","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1743-6109.2008.00949.x","article-title":"Risk factors for emotional and relationship problems in Peyronie's disease","volume":"5","author":"Smith","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0009","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie's disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2007.07.013","article-title":"The natural history of Peyronie's disease: an ultrasonography-based study","volume":"53","author":"Bekos","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0011","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/jsm.12334","article-title":"Peyronie's disease plaque calcification\u2014prevalence, time to identification, and development of a new grading classification","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0012","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fphar.2019.00312","article-title":"Ultrasound on erect penis improves plaque identification in patients with Peyronie's disease","volume":"10","author":"Liu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.urology.2020.08.045_bib0013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.urology.2018.06.003","article-title":"Plaque calcification: an important predictor of collagenase Clostridium histolyticum treatment outcomes for men with Peyronie's disease","volume":"119","author":"Wymer","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.urology.2020.08.045_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-5347(17)53599-5","article-title":"Mechanisms of calcification in Peyronie's disease","volume":"127","author":"Vande Berg","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-5347(17)42617-6","article-title":"Dystrophic penile calcification in Peyronie's disease","volume":"139","author":"Gelbard","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0016","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.juro.2009.12.026","article-title":"Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?","volume":"183","author":"Breyer","year":"2010","journal-title":"J Urol"},{"year":"2019","series-title":"Xiaflex (Collagenase clostridium histolyticum) for Injection, for Intralesional Use","author":"Endo","key":"10.1016\/j.urology.2020.08.045_bib0017"},{"key":"10.1016\/j.urology.2020.08.045_bib0018","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0019","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase Clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0020","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/j.esxm.2017.02.001","article-title":"Changes in the effects of Peyronie's disease after treatment with collagenase Clostridium histolyticum: male patients and their female partners","volume":"5","author":"Goldstein","year":"2017","journal-title":"Sex Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0021","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's Disease Questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0022","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies","volume":"116","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2020.08.045_bib0023","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/JU.0000000000000743","article-title":"Long-term safety and curvature deformity characterization in patients previously treated with collagenase Clostridium histolyticum for Peyronie's disease","volume":"203","author":"Goldstein","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0024","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.sxmr.2017.03.005","article-title":"Collagenase Clostridium histolyticum in the treatment of urologic disease: current and future impact","volume":"6","author":"Gabrielson","year":"2017","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.urology.2020.08.045_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1756287218755020","article-title":"Intralesional collagenase Clostridium histolyticum in the management of Peyronie's disease: current best practice","volume":"10","author":"Cwikla","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1756287216637569","article-title":"Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence","volume":"8","author":"Traore","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urology.2020.08.045_bib0027","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-year data","volume":"40","author":"Peimer","year":"2015","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.urology.2020.08.045_bib0028","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase Clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2020.08.045_bib0029","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease","volume":"35","author":"Gilpin","year":"2010","journal-title":"J Hand Surg Am"},{"key":"10.1016\/j.urology.2020.08.045_bib0030","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.sxmr.2017.12.006","article-title":"Objective assessments of Peyronie's disease","volume":"6","author":"Chen","year":"2018","journal-title":"Sex Med Rev"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520310943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429520310943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:11:30Z","timestamp":1758766290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429520310943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":30,"alternative-id":["S0090429520310943"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.045","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Curvature Deformity Characterization in Men Previously Treated With Collagenase Clostridium Histolyticum for Peyronie's Disease, Subgrouped by Penile Plaque Calcification","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2020.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}